Lassa fever vaccine

References

• Rose JR. A new clinical entity? Lancet 2, 197 (1956).
   Google Scholar
• Buckley SM, Casals J, Downs WG. Isolation and antigenic characterization of Lassa virus. Nature 227(254), 174 (1970).
   PubMed Web of Science ®Google Scholar
• Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. Isolation and characterization of the virus. Am. J. Trap. Med Hyg. 19(4), 680–691 (1970).
   Google Scholar
• McCormick JB. Arenaviruses. In: Fields Virology. (2nd ed.) Fields BN, Knipe DM (Eds), Raven Press, NY, USA, 1245–1267 (1990).
   Google Scholar
• Smit A, van der BH, Falk T, de Castro A. Biochemical genetic markers to identify two morphologically similar South African Mastomys species (Rodentia: Muridae). Bi ochem. Syst. Ecol. 29(1), 21–30 (2001).
   Google Scholar
• McCormick JB. Epidemiology and control of Lassa fever. Curr. Top. Microbial. Immunol. 134,69–78 (1987).
   PubMed Web of Science ®Google Scholar
• McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155(3), 437–444 (1987).
   Google Scholar
• •This paper describes the epidemiology and ecology of Lassa fever in great detail based on excellent primary data collected by the authors and clearly analyzed to demonstrate statistical significance of a wide range of important factors.
   Google Scholar
• Allan R, Ladbury R, Skinner K, Mardel S. Emergence of epidemic Lassa fever during civil conflict in Sierra Leone. Int. Conf Emerg. Infect. Dis. 134,21 (1998).
   Google Scholar
• Fisher-Hoch SP, Tomori 0, Nasidi A et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. MedJ. 311(7009), 857–859 (1995).
   Google Scholar
• •This paper comprehensively describes the problems associated with nosocomial transmission of Lassa fever.
   Google Scholar
• Lassa fever imported to England. Commun. Dis. Rep. CDR Wkly 10(11), 99 (2000).
   Google Scholar
• Lassa fever, imported case, Netherlands (news). Wkly Epidemi a Rec. 75(33), 265 (2000).
   Google Scholar
• Lassa fever, case imported to Germany (news). Wkly Epidemia Rec. 75(3), 17–18 (2000).
   Google Scholar
• Bishop DH, Auperin DD. Arenavirus gene structure and organization. Curr. Top. Microbial. Immunol. 133,5–17 (1987).
   PubMed Web of Science ®Google Scholar
• Bishop DH. Arenaviridae and their replication. In: Fields Virology (2nd ed.) Fields BN, Knipe DM (Eds), Raven Press, NY, USA, 1231–1243 (1993).
   Google Scholar
• Salvato MS, Schweighofer KJ, Burns J, Shimomaye EM. Biochemical and immunological evidence that the 11 kDa zinc-binding protein of lymphocytic choriomeningitis virus is a structural component of the virus. Vir Res. 22(3), 185–198 (1992).
   Google Scholar
• US Department of Health and Human Services, and National Institutes of Health. In: Biosafeot in Microbiological and Biomedical Laboratories. Richmond JY, McKinney RW (Eds), Government Printing Office, DC, USA (1999).
   Google Scholar
• Bowen MD, Peters CJ, Nichol ST Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mal. Phylogenet EvoL 8(3), 301–316 (1997).
   PubMed Web of Science ®Google Scholar
• Bowen MD, Rollin PE, Ksiazek TG et al. Genetic diversity among Lassa virus strains. J. Viral. 74(15), 6992–7004 (2000).
   PubMed Web of Science ®Google Scholar
• Riviere Y. Mapping arenavirus genes causing virulence. Curr. Top. Microbial. Immunol. 133,59–65 (1987).
   PubMed Web of Science ®Google Scholar
• Djavani M, Lukashevich IS, Salvato MS. Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea-pigs. Virus Genes 17(2), 151–155 (1998).
   PubMed Web of Science ®Google Scholar
• Trappier SG, Conaty AL, Farrar BB et al. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am. J. Trap. Med. Hyg. 49(2), 214–221 (1993).
   Google Scholar
• Drosten C, Gottig S, Schilling S et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, Dengue Virus, and Yellow Fever Virus by real-time reverse transcription-PCR. J. Clin. Microbial. 40(7), 2323–2330 (2002).
   Google Scholar
• Baize S, Leroy EM, Georges-Courbot MC et al. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5(4), 423–426 (1999).
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Mitchell SW, Sasso DR et al. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis. 155(3), 465–474 (1987).
   Google Scholar
• Cao W, Henry MD, Borrow P et at. Identification of a-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus. Science 282(5396), 2079–2081 (1998).
   PubMed Web of Science ®Google Scholar
• Spiropoulou CF, Kunz S, Rollin PE, Campbell KP, Oldstone MB. New World arenavirus dade C, but not clade A and B viruses, utilizes a-dystroglycan as its major receptor.j Vim/. 76(10), 5140–5146 (2002).
   Google Scholar
• Auperin DD, McCormick JB. Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. Virology 168(2), 421–425 (1989).
   PubMed Web of Science ®Google Scholar
• Ruo SL, Mitchell SW, Kiley MP et al. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J. Gen. Viral. 72(3), 549–555 (1991).
   Google Scholar
• Fisher-Hoch SP, Hutwagner L, Brown B, McCormick JB. Effective vaccine for Lassa fever." Viral. 74(15), 6777–6783 (2000).
   Google Scholar
• •This paper contains a comprehensive account of vaccine efficacy in nonhuman primates.
   Google Scholar
• Webb PA, McCormick JB, King IJ et al. Lassa fever in children in Sierra Leone, West Africa. Trans. R. Soc. Trap. Med. Hyg. 80(4), 577–582 (1986).
   Google Scholar
• Fraser DW, Campbell CC, Monath TP, Goff PA, Gregg MB. Lassa fever in the Eastern Province of Sierra Leone, 1970–1972. Epidemiologic studies. Am. J. Trap. Med Hyg 23(6), 1131–1139 (1974).
   Google Scholar
• Monath TP, Mertens PE, Patton R et al. A hospital epidemic of Lassa fever in Zorzor, Liberia, March—April 1972. Am. J. Trap. Med. Hyg. 22(6), 773–779 (1973).
   Google Scholar
• Helmick CG, Webb PA, Scribner CL, Krebs JW, McCormick JB. No evidence for increased risk of Lassa fever infection in hospital staff. Lancet 2(8517), 2–5 (1986).
   Web of Science ®Google Scholar
• Fisher-Hoch SR Stringent precautions are not advisable when caring for patients with viral haemorrhagic fevers. Rev. Med Viral. 3,7–13 (1993).
   Google Scholar
• McCormick JB. Clinical, epidemiologic, and therapeutic aspects of Lassa fever. Med. Microbi ol. Immunol. 175(2–3), 153–155 (1986).
   Google Scholar
• Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br. Med. J. 297(6648), 584–587 (1988).
   Google Scholar
• Cummins D, McCormick JB, Bennett D et al. Acute sensorineural deafness in Lassa fever [see comments]. JAMA 264(16), 2093–2096 (1990).
   PubMed Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA et al. Lassa fever. Effective therapy with ribavirin. N Engl. Med. 314(1), 20–26 (1986).
   Google Scholar
• •This paper describes the clinical trials showing ribavirin efficacy.
   Google Scholar
• Severson WE, Schmaljohn CS, Javadian A, Jonsson CB. Ribavirin causes error catastrophe during Hantaan virus replication. Viro/. 77(1), 481–488 (2003).
   Google Scholar
• Lassa fever imported to England. Commun. Dis. Rep. CDR Wkly, 10(11), 99 (2000).
   Google Scholar
• Maiztegui JI, Fernandez NJ, de Damilano AJ. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome. Lancet 2(8154), 1216–1217 (1979).
   PubMed Web of Science ®Google Scholar
• Johnson KM, McCormick JB, Webb PA et al. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155(3), 456–464 (1987).
   Google Scholar
• Jahrling PB. Protection of Lassa virus- infected guinea-pigs with Lassa-immune plasma of guinea-pig, primate, and human origin.' Med. Vire/. 12(2), 93–102 (1983).
   Web of Science ®Google Scholar
• Jahrling PB, Peters CJ. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect. Immun. 44(2), 528–533 (1984).
   PubMed Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA et al. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155(3), 445–455 (1987).
   Google Scholar
• Enria DA, Briggiler AM, Fernandez NJ, Levis SC, Maiztegui JI. Importance of dose of neutralizing antibodies in treatment of Argentine haemorrhagic fever with immune plasma. Lancet 2(8397), 255–256 (1984).
   PubMed Web of Science ®Google Scholar
• Ter Meulen J, Badusche M, Kuhnt K et al. Characterization of human CD4C) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Viral. 74(5), 2186–2192 (2000).
   Google Scholar
• McCormick JB, Mitchell SW, Kiley MP, Ruo S, Fisher-Hoch SP. Inactivated Lassa virus elicits a nonprotective immune response in rhesus monkeys. J. Med. Viral. 37(1), 1–7 (1992).
   Google Scholar
• Clegg JC, Oram JD. Molecular cloning of Lassa virus RNA: nucleotide sequence and expression of the nucleocapsid protein gene. Virology 144(2), 363–372 (1985).
   PubMed Web of Science ®Google Scholar
• Clegg JC, Lloyd G. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guinea-pigs against Lassa fever. Lancet 2(8552), 186–188 (1987).
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, McCormick JB, Auperin DD et al. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Nad Acad. Sci. USA 86(1), 317–321 (1989).
   Google Scholar
• Auperin DD, Esposito JJ, Lange JV et al. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea-pigs from a lethal Lassa virus infection. Virus Res. 9(2-3), 233–248 (1988).
   Google Scholar
• Morrison HG, Bauer SP, Lange JV et al. Protection of guinea-pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 171(1), 179–188 (1989).
   PubMed Web of Science ®Google Scholar
• Morrison HG, Goldsmith CS, Regnery HL, Auperin DD. Simultaneous expression of the Lassa virus Nand GPC genes from a single recombinant vaccinia virus. Virus Res. 18(2-3), 231–241 (1991).
   Google Scholar
• Marta RF, Enria D, Molinas FC. Relationship between hematopoietic growth factors levels and hematological parameters in Argentine hemorrhagic fever. Am.j Hematol 64(1), 1–6 (2000).
   Google Scholar
• Kiley MP, Lange JV, Johnson KM. Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus [letter]. Lancet 2(8145), 738 (1979)•.
   Google Scholar
• Rice CM. Overview of flavivirus molecular biology and future vaccine development via recombinant DNA. Southeast Asian Trap. Med. Public Health 21(4), 670–677 (1990).
   Google Scholar
• Levine MM, Levine OS. Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Lancet 350(9088), 1386–1392 (1997).
   PubMed Web of Science ®Google Scholar
• Ruff TA. Immunization strategies for viral diseases in developing countries. Rev. Med. Viral. 9(2), 121–138 (1999).
   Google Scholar
• Cohen J. Public health. Gates Foundation rearranges public health universe. Science 295(5562), 2000 (2002).
   PubMed Web of Science ®Google Scholar
• Mitchell SW, McCormick JB. Physicochemical inactivation of Lassa, Ebola, and Marburg viruses and effect on clinical laboratory analyses. J. Clin. Microbial 20(3), 486–489 (1984). Affiliations.
   Google Scholar